Loading...
VUZI is not a good buy right now. The setup is still technically weak (below key pivot with bearish MACD) and fundamentals are deteriorating (revenue down YoY with widening losses). While options positioning is very call-heavy and the stock looks oversold enough for a short bounce, there are no proprietary buy signals today and the next catalyst (earnings on 2026-02-12) is more of a risk event than a clear upside driver. For an impatient buyer looking for an immediate, higher-confidence entry, I would avoid buying here.
Trend remains bearish/weak: price (~2.64) is below the pivot (2.91) and sitting just above near-term support S1 (2.587). MACD histogram is negative (-0.0898), though contracting, implying downside momentum is slowing but not reversed. RSI(6) ~24 is deeply oversold, which can support a short-term bounce, but oversold alone is not a buy signal without confirmation. Moving averages are converging (indecision), and pattern-based outlook is mildly negative over 1W and 1M (-0.59% / -2.35%), suggesting any bounce may be limited unless price reclaims 2.91 and then 3.23 (R1).

and sitting near support (2.59 area), which can fuel a reflex bounce. Options positioning is heavily call-skewed, indicating bullish speculation and potential for sharp upside bursts. Upcoming earnings (2026-02-12 after hours) could be a catalyst if results/guidance surprise positively.
with negative MACD, implying the path of least resistance remains down/sideways. No supportive news flow in the past week. Earnings is an event-risk catalyst (could pressure shares further given weak recent fundamentals). Elevated IV suggests the market expects large moves and increases the probability of sharp downside as well.
Latest reported quarter: 2025/Q3. Revenue fell to ~$1.16M (-16.22% YoY). Net income worsened to about -$7.38M (down -20.03% YoY), and EPS declined to -0.10 (-28.57% YoY). Gross margin improved YoY but remains negative (-71.98), signaling the core business is still not operating at sustainable economics. Overall: shrinking revenue with widening losses is a bearish growth trend heading into the next earnings season.
No analyst rating/price target change data was provided, so recent Wall Street upgrades/downgrades and target trends cannot be confirmed here. Pros typically cited for this type of stock: optionality on adoption/partnerships in AR smart glasses. Cons: persistent losses, weak revenue trajectory, and high uncertainty into earnings.